Health & Pharm General

PositiveSingles® Launches 'Deeply Honest Questions' in Private Chat

🕔4/28/2025 11:05:44 AM

PositiveSingles®, the largest and most trusted dating platform for singles living with sexually transmitted diseases (STDs), announced a new chat-based feature called “Deeply Honest Questions.

Read Full Article

Feroot Launches AlphaPrivacy AI: Automating Global Privacy Compliance for Websites and Web Applications

🕔4/28/2025 10:30:00 AM

Feroot Security, a leader in web application security and compliance, today announced the launch of AlphaPrivacy AI, an AI-powered platform designed to automate privacy compliance for enterprise websites and web applications.

Read Full Article

Dr. Sud Agarwal and iNGENu CRO Lead Asia-Pacific in Complex Trials for Profound Neurodevelopmental Disorders

🕔4/28/2025 9:01:48 AM

iNGENu CRO, a full-service contract research organization headquartered in Australia, has announced its strategic focus and growing leadership in complex paediatric clinical trials, specifically involving profoundly intellectually and physically disabled children with rare neurodevelopmental conditions.

Read Full Article

Jack Herer Enters Global Pharma Market Through Partnership with SOMAÍ

🕔4/28/2025 8:00:00 AM

The Jack Herer Brand, an iconic U.S.-based cannabis company, has announced a strategic partnership with SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines.

Read Full Article

New Book 'The Brain Always Wins 2' Aims to Enhance Well-being and Performance

🕔4/28/2025 6:00:00 AM

Chiselbury Publishing is proud to announce the release of "The Brain Always Wins 2," a transformative book co-authored by leading Clinical Sport Psychologist Dr.

Read Full Article

Australian Teens Embrace Reusable Period Care: New Guide Highlights First-Time Use of Menstrual Discs

🕔4/25/2025 9:08:02 AM

A new guide released this month explores how Australian teenagers are leading a shift in menstrual care preferences, with many embracing reusable products like menstrual discs as their first choice.

Read Full Article

Contraline Announces 24-Month Safety and Efficacy Results from First-in-Human Trial of ADAM™

🕔4/24/2025 12:00:00 PM

Contraline, a clinical-stage male contraception company, today announced that participants in the First-in-Human clinical trial of ADAM™ (“The ADAM Study”) have reached a critical milestone, demonstrating both safety and efficacy at the 24-month mark.

Read Full Article